Intellectual Property India Publishes Patent Application for 'Pharmaceutical Composition For Prevention Or Treatment Of Drug-Related Peptic Ulcer Comprising Zastaprazan Or Pharmaceutically Acceptable Salt Thereof' Filed by Jeil Pharmaceutical Co. Ltd.; and Onconic Therapeutics Inc.

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517060343 A) filed by Jeil Pharmaceutical Co. Ltd.; and Onconic Therapeutics Inc., Seoul, Republic of Korea, on June 24, for 'pharmaceutical composition for prevention or treatment of drug-related peptic ulcer comprising zastaprazan or pharmaceutically acceptable salt thereof.'

Inventor(s) include Kim, John; Cha, Hyun Ju; and Han, Sang Woo.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "Disclosed in the present invention is a pharmaceutical composition for the prevention or treatment of drug-related peptic ulcer, comprising zastaprazan or a pharmaceutically acceptable salt thereof."

The patent application was internationally filed on Nov. 29, 2023, under International application No.PCT/KR2023/019493.

Disclaimer: Curated by HT Syndication.